Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank43
3Y CAGR+18.3%
5Y CAGR-28.9%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+18.3%/yr
vs -32.5%/yr prior
5Y CAGR
-28.9%/yr
Recent acceleration
Acceleration
+50.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.96 | +14.4% |
| 2024 | 2.58 | +526.7% |
| 2023 | 0.41 | -76.9% |
| 2022 | 1.78 | -80.5% |
| 2021 | 9.16 | -43.6% |
| 2020 | 16.26 | +295.6% |
| 2019 | 4.11 | -52.2% |
| 2018 | 8.60 | +73.7% |
| 2017 | 4.95 | -33.7% |
| 2016 | 7.47 | - |